Author
Listed:
- Nitesh Kumar Khandelwal
(University of California San Francisco
Oregon Health & Science University)
- Meghna Gupta
(University of California San Francisco
Oregon Health & Science University)
- James E. Gomez
(Broad Institute of MIT and Harvard)
- Sulyman Barkho
(Broad Institute of MIT and Harvard)
- Ziqiang Guan
(Duke University Medical Center)
- Ashley Y. Eng
(Broad Institute of MIT and Harvard)
- Tomohiko Kawate
(Broad Institute of MIT and Harvard)
- Sree Ganesh Balasubramani
(University of California San Francisco)
- Andrej Sali
(University of California San Francisco)
- Deborah T. Hung
(Broad Institute of MIT and Harvard
Harvard Medical School
Massachusetts General Hospital)
- Robert M. Stroud
(University of California San Francisco)
Abstract
A broad chemical genetic screen in Mycobacterium tuberculosis (Mtb) identified compounds (BRD-8000.3 and BRD-9327) that inhibit the essential efflux pump EfpA. To understand the mechanisms of inhibition, we determined the structures of EfpA with these inhibitors bound at 2.7-3.4 Å resolution. Our structures reveal different mechanisms of inhibition by the two inhibitors. BRD-8000.3 binds in a tunnel contacting the lipid bilayer and extending toward the central cavity to displace the fatty acid chain of a lipid molecule bound in the apo structure, suggesting its blocking of an access route for a natural lipidic substrate. Meanwhile, BRD-9327 binds in the outer vestibule without complete blockade of the substrate path to the outside, suggesting its possible inhibition of the movement necessary for alternate access of the transporter. Our results show EfpA as a potential lipid transporter, explain the basis of the synergy of these inhibitors and their potential for combination anti-tuberculosis therapy.
Suggested Citation
Nitesh Kumar Khandelwal & Meghna Gupta & James E. Gomez & Sulyman Barkho & Ziqiang Guan & Ashley Y. Eng & Tomohiko Kawate & Sree Ganesh Balasubramani & Andrej Sali & Deborah T. Hung & Robert M. Stroud, 2025.
"Structure and inhibition mechanisms of Mycobacterium tuberculosis essential transporter efflux protein A,"
Nature Communications, Nature, vol. 16(1), pages 1-13, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-58133-6
DOI: 10.1038/s41467-025-58133-6
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-58133-6. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.